Jamie Galloway, Author at IORBC

A randomised, sham controlled trial of dorsal root rhizotomy stereotactic radiosurgery versus standard of care for spasticity associated with stroke, spinal cord injury & cerebral palsy

A Randomized, Sham Controlled Trial of Dorsal Root Rhizotomy Stereotactic Radiosurgery Versus Standard of Care for Spasticity Associated With Stroke, Spinal Cord Injury & Cerebral Palsy. The landscape of medical interventions for spasticity management is continuously evolving and The International Organisation for Radiotherapy for Benign

Radon bath treatment to undergo placebo-controlled study

The use of radon baths for therapeutic purposes, particularly in treating chronic degenerative, inflammatory, and musculoskeletal conditions such as arthritis, osteoarthritis, and heel spurs, has been used for over 100 years – yet the molecular mechanisms behind the treatment are largely unexplored. The International Organisation

LoRD-KNeA trial on Low Does Radiotherapy as a potential treatment for knee osteoarthritis

The International Organisation for Radiotherapy for Benign Conditions (IORBC) welcomes a significant advancement in osteoarthritis (OA) treatment research with the prospective LoRD-KNeA trial by Byoung Hyuck Kim and colleagues, published in the BMJ Open. The trial will represent a pioneering effort in exploring low-dose radiation

Parkinsonism

Radiotherapy to parotid or submandibular glands is effective for drooling in patients with Parkinsonism

A randomised double-blind placebo-controlled trial has shown radiation of parotid or submandibular glands to be successful in the treatment of drooling in Parkinsonian patients. Drooling occurs in 32 – 74% of patients with Parkinsonism. It is mainly caused by impaired swallowing of saliva. This can

Osteoarthritis

ArthroRad 3 & 12 month trial report & questions with Prof. Niewald

ArthroRad 3 & 12 month follow up research: Pioneering single-blinded research trials in low dose radiotherapy for Osteoarthritis IORBC are pleased to share this summary on the ArthroRad trial for low-dose radiotherapy for osteoarthritis (OA) which was conducted by Niewald et al, a team

Osteoarthritis

Miszczyk et. al study examines the efficacy of stereotactic arrhythmia radioablation (STAR) on patients with ventricular tachycardia (VT)

Miszczyk et. al study examines the efficacy of stereotactic arrhythmia radioablation (STAR) on patients with ventricular tachycardia (VT) Whilst the IORBC has recently focused more heavily on the use of radiotherapy treatment (RT) for Musculoskeletal conditions, in this post, we examine a recent study

Benign diseases

Our summary of the key points from a recent patterns of care survey measuring radiotherapy use for benign diseases in Turkey

The recent article Radiotherapy for benign diseases in Turkey: a patterns of care survey of the Turkish Society for Radiation Oncology (TROD 05-002) provides an interesting insight into the use of radiotherapy to treat benign diseases in the country — including its uptake and barriers.

Is there still a role for radiation therapy in the management of benign disease

Clinical Oncology

Our thoughts on Clinical Oncology journal’s recent op-ed on radiotherapy for benign disease

The latest Clinical Oncology journal contains a well-balanced editorial from Bruno Fionda and Agata Rembielak which clearly sets out the issues that are holding back radiotherapy for benign diseases from wider adoption, which can be summarised as follows: Emergence of Alternative Treatments:Particularly the development of

Keloid

Advances in Keloid Scar Management – Insights from Mr. Ioannis Goutos’ Alatro webinar presentation

At a recent Alatro webinar in July, Mr. Ioannis Goutos, a consultant plastic surgeon with a special interest in scar management, shared his experience and clinical expertise in a presentation covering various aspects of keloid scarring, from pathophysiology to innovative approaches in treatment. Mr. Goutos

IORBC at the Xstrahl booth at ASTRO 2023

ASTRO 2023

Meet Xstrahl and Explore Advancements in Radiotherapy at ASTRO 2023

In anticipation of the ASTRO 2023 Annual Meeting in San Diego, California from October 1st to 4th, the International Organization for Radiation for Benign Conditions (IORBC) invites you to meet our founding sponsor, Xstrahl, a leading provider of radiotherapy solutions, at their stand at the

Send a message.

careers